Last reviewed · How we verify
NCT05547269
PROMs and Patellar Tracking After MPFL Reconstruction With or Without Tibial Tuberosity Transposition
trial in Patellar Dislocation in 11 participants. Terminated before completion.
20 May 2025
Quick facts
| Lead sponsor | Radboud University Medical Center |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 11 |
| Start date | 17 February 2023 |
| Primary completion | 20 May 2025 |
| Estimated completion | 20 May 2025 |
| Sites | 1 location across Netherlands |
Conditions studied
- Patellar Dislocation — all drugs for Patellar Dislocation →
- Patellar Dislocation, Recurrent — all drugs for Patellar Dislocation, Recurrent →
- Patellofemoral Maltracking — all drugs for Patellofemoral Maltracking →
Sponsor
Radboud University Medical Center
Who can join
16 and older, any sex, with Patellar Dislocation or Patellar Dislocation, Recurrent. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Patellar dislocations cause pain and functional decline in adolescents, which can be restored by a MPFL reconstruction with or without tibial tuberosity transposition. Yet, many reconstruction methods are being used clinically as consensus on the ideal MPFL reconstruction method is lacking. We propose a soft-tissue loop reconstruction method which potentially decreases the risk for of iatrogenic fracture of the patella and prevents femoral tunnel malposition.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05547269
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Patellar Dislocation
Currently open trials in the same condition.
- NCT06086080 — Non-operative Treatment in First-time Patellar Dislocation · NA · recruiting
- NCT04607538 — The Faroese Knee Cohort: Etiology and Long-term Implications of Trochlear Dysplasia and Patellar Dislocations. · recruiting
- NCT04554212 — Blood Flow Restriction Training After Patellar INStability · NA · recruiting
- NCT04294199 — Effect of Early Range of Motion Following First Time Patellar Dislocation · NA · active not recruiting
- NCT05706363 — Comparison of Two Graft Choices in Mediale Patellofemoral Ligament Reconstruction (MPFL) · NA · active not recruiting
Other Radboud University Medical Center trials
Trials by the same sponsor.
- NCT07485569 — Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial · Phase 1 · not yet recruiting
- NCT07514325 — MR-guided Adaptive Stereotactic Radiotherapy for Endometrial Cancer · NA · not yet recruiting
- NCT07530263 — Deposition of Inhaled Liposomal Amphotericin B in Chronic Pulmonary Aspergillosis (CPA) · Phase 1 · not yet recruiting
- NCT07532577 — Intranasal Insulin to Prevent Intensive Care Unit Delirium · Phase 2, PHASE3 · not yet recruiting
- NCT07504172 — Real-world Effectiveness and Dosing Patterns of Tirzepatide in People With Obesity · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05547269 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Radboud University Medical Center
- Last refreshed: 6 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05547269.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing